On January 9th, the company held a symposium for renowned Hunan traditional Chinese medicine (TCM) practitioners and the first working meeting of the clinical guidance expert group at its Liuyang production base. The experts attending the meeting included Professor Bai Zhengping, a doctoral supervisor, recipient of the special government allowance from the State Council, and a nationally renowned TCM practitioner; Professor Yao Qin, chief physician at the Affiliated Hospital of Hunan Provincial Traditional Chinese Medicine Research Institute; Professor Bu Xianchun, a renowned TCM practitioner; and Huang Jiangbo, chief physician at the Affiliated Hospital of Hunan Provincial Traditional Chinese Medicine Research Institute. The expert group visited the company's exhibition hall, formula granules production line extraction workshop, traceability linkage line packaging workshop, drug research institute, and quality inspection center in succession, and then held a symposium in the conference room.

On behalf of the company, Chairman Shen Fanshun extended a warm welcome to all the distinguished senior traditional Chinese medicine practitioners attending the meeting. He introduced the current basic situation and future development plan of the company, and expressed gratitude to the expert team for their support in product clinical application, academic promotion, and other work.

The expert panel fully affirmed the company's development in recent years and suggested that the company should, in the future: first, pursue a path of distinctive development, retain and carry forward the banner of "ultra-micro traditional Chinese medicine (TCM)", and make up for the deficiencies of TCM formula granules; second, adopt a multi-pronged approach, inherit and innovate, strengthen scientific research, and effectively develop and apply classic prescriptions; third, ensure the quality of medicinal materials from the source, strengthen quality control in every production process, and produce products that doctors and patients can trust.

Members of the company's leadership team, as well as heads of relevant departments such as the Drug Research Institute, Marketing Center, and Administrative Center, attended the meeting.